New funding supports enterprise and health plan growth as the company unveils Care Hub and Care Scribe, transforming care delivery through AI

SAN FRANCISCO–(BUSINESS WIRE)–WellTheory, the leading whole-person care platform for autoimmune disease, today announced the close of $5M in new funding and the successful rollout of its proprietary AI tools, Care Hub and Care Scribe, across its care operations. New investors Samsung Next, Opal Ventures, and Up2 Fund joined the round, with continued support from existing investors Accel, OVO Fund, and BoxGroup.

These milestones mark a major leap forward in the company’s mission to make autoimmune care more accessible, scalable, and effective for the 50 million Americans navigating these chronic conditions, such as rheumatoid arthritis, lupus and multiple sclerosis. The new capital will fuel WellTheory’s expansion into the employer and health plan markets, and accelerate the development of its AI-powered care infrastructure for both providers and members.

“AI is no longer a nice-to-have in care delivery — its essential infrastructure,” said Ellen Rudolph, CEO and Co-founder of WellTheory. “This new round of funding is allowing us to double down on our AI strategy, streamline the most time-consuming parts of care, and expand into new markets. We’re leading the charge in making whole-person, root-cause care more accessible, personalized, and effective — and bringing it to scale through our growing partnerships with employers and health plans.”

WellTheory’s Care Scribe, the company’s proprietary AI assistant, now supports its Care Team by attending member sessions, transcribing conversations, and drafting follow-up notes and personalized Care Plans — all for provider review and customization. The tool has reduced provider prep and documentation time by 65%, enabling a more efficient and focused care experience.

Alongside Care Scribe, the newly launched Care Hub acts as the unified command center for WellTheory’s providers — aggregating member data, session history, and lab insights in one place. With dynamic workflows tailored to each session type, the Care Hub streamlines pre- and post-session tasks and enables automated compliance tracking. The result is a smoother care journey for both providers and members.

“Care delivery for patients with autoimmune disease is incredibly complex—our team built these tools to help give our Care Team time back for what matters most: supporting our members,” said Claire Rudolph, Co-Founder and Head of Product at WellTheory. “With WellTheory’s Care Hub and Care Scribe, we’re building the modern infrastructure autoimmune care has always needed — intelligent, integrated systems that streamline repetitive tasks, amplify what makes care human, and equip our team to deliver more personalized, responsive support at scale.”

This meta-intelligence will power a more personalized, proactive experience for members, surfacing symptom patterns, optimizing interventions, and enabling the Care Team to deliver precision support at scale. By connecting the dots across a fragmented care journey, WellTheory aims to not only reduce the burden of autoimmune disease — but also to fundamentally reimagine how it’s managed.

With the Care Hub and Care Scribe now fully deployed, WellTheory is focused on what comes next: leveraging its growing ecosystem of data — including session transcripts, lab results, symptom tracking, lifestyle inputs, and provider insights — to build a next-generation intelligence layer across the member journey. Future product investments include deeper automation in areas like lab workflows and scheduling, expanded analytics and care optimization tools for providers, and a reimagined member-facing experience grounded in personalization, guidance, and long-term engagement.

About WellTheory:

WellTheory is a virtual care platform reversing the autoimmune epidemic by filling the gaps left behind in traditional healthcare. WellTheory offers a research-backed proprietary program that addresses the root cause of autoimmunity and treats the whole person with the aim to reduce symptoms, improve quality of life, and lower costs. WellTheory’s platform centers around evidence-based, high-touch care led by an interdisciplinary team of autoimmune experts, including licensed registered dietitians and board-certified health coaches. It’s an anti-symptom-masking model that goes beyond the pill, built by autoimmune patients and validated by decades of clinical research.

Contacts

Hanna Refvik
welltheory@solcomms.co

(c)2025 Business Wire, Inc., All rights reserved.